Ignite Creation Date:
2024-05-06 @ 3:32 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04667793
Status:
RECRUITING
Last Update Posted:
2023-04-04
First Post:
2020-12-05
Brief Title:
Clinical Study of Neoadjuvant PD-1 Antibody Toripalimab Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor
Sponsor:
Shanghai Pulmonary Hospital Shanghai China
Organization:
Shanghai Pulmonary Hospital Shanghai China
Organization Data
Organization:
Shanghai Pulmonary Hospital Shanghai China
Class:
OTHER
Study ID:
ChestMate-001FK-NEO-TET-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Pulmonary Hospital Shanghai China
Lead Sponsor Class:
OTHER
Responsible Party:
Peng Zhang
Responsible Party Title:
Director of science and education department
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shanghai Pulmonary Hospital Shanghai China
Old Name:
None
Old Organization:
None